No Prescription |
 |
 | ||
|
Azee Zithromax TRI PAK |
|
| ||
No Prescription » Prescription Drugs 2 » Azee Zithromax TRI PAK Azithromycin is in a group of drugs called macrolide antibiotics. Azithromycin fights bacteria in the body.Azithromycin is used to treat many different types of infections caused by bacteria such as respiratory infections skin infections ear infections and sexually transmitted diseases.Azithromycin is used for: Treating mild to moderate infections caused by certain bacteria. It may also be used alone or with other medicines to treat or prevent certain infections in persons with advanced HIV infection. Azithromycin (az-ith-roe-MYE-sin) is used to treat bacterial infections in many different parts of the body. It is also used to prevent Mycobacterium avium complex (MAC) disease in patients infected with the human immunodeficiency virus (HIV). It works by killing bacteria or preventing their growth. However this medicine will not work for colds flu or other viral infections. Azithromycin may be used for other problems as determined by your doctor. Buy Azee Zithromax TRI PAK and other Prescription Drugs 2 products online at Medstore. Buy Online at Medstore - Click Here!
About Azee Zithromax TRI PAK: Product Type: Prescription Drugs 2 Azee ( Zithromax TRI-PAK Zithromax Z-Pak Zmax Generic Azithromycin ) Azee (Zithromax TRI-PAK Zithromax Z-Pak Zmax Generic Azithromycin) Zithromax TRI-PAK Zithromax Z-Pak Zmax Generic Azithromycin 100mg 30 Disp.Tablets 100mg 90 Disp.Tablets 250mg 18 Tablets 250mg 36 Tablets 250mg 6 Tablets 500mg 9 Tablets 500mg 18 Tablets 500mg tabs 3 Zithromax TRI-PAK Zithromax Z-Pak Zmax Generic Azithromycin Azee
View more Prescription Drugs 2 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
